Lucy Shneyer

448 total citations
12 papers, 230 citations indexed

About

Lucy Shneyer is a scholar working on Pediatrics, Perinatology and Child Health, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lucy Shneyer has authored 12 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lucy Shneyer's work include Pharmaceutical studies and practices (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Allergic Rhinitis and Sensitization (2 papers). Lucy Shneyer is often cited by papers focused on Pharmaceutical studies and practices (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Allergic Rhinitis and Sensitization (2 papers). Lucy Shneyer collaborates with scholars based in United States, India and United Kingdom. Lucy Shneyer's co-authors include Nan M. Laird, Garrett M. Fitzmaurice, Eli O. Meltzer, Mark S. Dykewicz, Dana Wallace, Chin‐Chung Lin, Elaine Radwanski, Melton B. Affrime, Melvin D. Brannan and Pascale Reidenberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Lucy Shneyer

10 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucy Shneyer United States 7 77 74 53 29 29 12 230
Roger Yu United States 7 112 1.5× 65 0.9× 34 0.6× 3 0.1× 29 1.0× 11 452
Matthew T. Taylor United States 9 19 0.2× 28 0.4× 27 0.5× 6 0.2× 52 1.8× 20 232
Marija Kalaba Sweden 8 13 0.2× 33 0.4× 36 0.7× 8 0.3× 62 2.1× 10 418
Caroline C. Horner United States 8 124 1.6× 96 1.3× 28 0.5× 28 1.0× 12 416
Elisabeth Bakker Netherlands 12 22 0.3× 340 4.6× 31 0.6× 33 1.1× 91 3.1× 21 648
Laura Sottosanti Italy 9 8 0.1× 14 0.2× 48 0.9× 5 0.2× 53 1.8× 19 270
Jonas Häggström Canada 7 5 0.1× 20 0.3× 24 0.5× 44 1.5× 22 0.8× 8 218
Yukari Kamijima Japan 6 10 0.1× 52 0.7× 194 3.7× 2 0.1× 14 0.5× 8 307
Jianchao Quan Hong Kong 10 8 0.1× 19 0.3× 29 0.5× 2 0.1× 5 0.2× 33 281
Matthew P. Gray United States 13 6 0.1× 15 0.2× 13 0.2× 7 0.2× 21 0.7× 32 432

Countries citing papers authored by Lucy Shneyer

Since Specialization
Citations

This map shows the geographic impact of Lucy Shneyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Shneyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Shneyer more than expected).

Fields of papers citing papers by Lucy Shneyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Shneyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Shneyer. The network helps show where Lucy Shneyer may publish in the future.

Co-authorship network of co-authors of Lucy Shneyer

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Shneyer. A scholar is included among the top collaborators of Lucy Shneyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Shneyer. Lucy Shneyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Donath, Frank, et al.. (2018). A randomized, open-label, crossover study evaluating bioequivalence of two N-acetylcysteine 2% oral solution formulations in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 56(9). 417–425.
2.
Mason, Stephen, et al.. (2017). Clinical study to monitor dentinal hypersensitivity with episodic use of a desensitising dentifrice. BDJ Open. 3(1). 17011–17011. 3 indexed citations
3.
4.
Meltzer, Eli O., Dana Wallace, Mark S. Dykewicz, & Lucy Shneyer. (2016). Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?. The Journal of Allergy and Clinical Immunology In Practice. 4(4). 682–688.e6. 60 indexed citations
5.
Lambert, John M., Michael S. Wyand, Cheryl Lassen, et al.. (2016). Bioavailability, safety and immunogenicity of biosimilar infliximab (BOW015) compared to reference infliximab. International Journal of Clinical Pharmacology and Therapeutics. 54(4). 315–322. 18 indexed citations
6.
Kay, Jonathan, Arvind Chopra, S Chandrashekara, et al.. (2015). AB0420 Secondary Efficacy Outcomes from a Phase 3 Study Support Clinical Equivalence Between BOW015 and Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses. Annals of the Rheumatic Diseases. 74. 1034–1034. 5 indexed citations
7.
8.
9.
10.
Banfield, Christopher, et al.. (2003). Desloratadine suppresses histamine- and allergen-induced cutaneous wheal and flare responses in allergic subjects during 6 months' treatment. Journal of Allergy and Clinical Immunology. 111(2). S235–S235. 1 indexed citations
11.
Fitzmaurice, Garrett M., Nan M. Laird, & Lucy Shneyer. (2001). An alternative parameterization of the general linear mixture model for longitudinal data with non‐ignorable drop‐outs. Statistics in Medicine. 20(7). 1009–1021. 52 indexed citations
12.
Brannan, Melvin D., Pascale Reidenberg, Elaine Radwanski, et al.. (1995). Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations*. Clinical Pharmacology & Therapeutics. 58(3). 269–278. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Yu Breakdown of academic impact, for papers by Matthew T. Taylor Breakdown of academic impact, for papers by Marija Kalaba Breakdown of academic impact, for papers by Caroline C. Horner Breakdown of academic impact, for papers by Elisabeth Bakker Breakdown of academic impact, for papers by Laura Sottosanti Breakdown of academic impact, for papers by Jonas Häggström Breakdown of academic impact, for papers by Yukari Kamijima Breakdown of academic impact, for papers by Jianchao Quan Breakdown of academic impact, for papers by Matthew P. Gray
Rankless by CCL
2026